BYND Calls Pop on Snoop Dogg Deal

The "phase one" trade deal will reportedly be inked later this week

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     1/13/2020
This Pot Stock Could Be The Next Procter & Gamble A tiny cannabis company is about to disrupt Latin America's $31.98 billion cosmetics industry with a revolutionary new line of CBD beauty products. Then it's on to conquer CBD health care...skin care...and even the pet care markets. So far this company's flying under Wall Street's nose... But not for long.
Stocks Remain Higher on Trade Deal Optimism By Lillian Currens Share On With the signing of the "phase one" trade deal apparently just days away, the Dow Jones Industrial Average (DJI) is continuing its climb midday. The blue chip index is joined in positive territory by the S&P 500 Index (SPX) and Nasdaq Composite (IXIC), though upside has been fairly limited overall. Meanwhile, February-dated crude futures are sliding, as tensions between the U.S. and Iran slide further into the rear view, down 1.2% to trade at $58.33 per barrel.  Continue reading for more on today's market, including: How red-hot Lululemon stock just nabbed another fresh high.  The blue chip slipping on a scathing bear note from Evercore ISI.  Plus, BYND calls pop on Snoop Dogg deal; ADAP doubles amid promising cell therapy data; and Stage Stores stock hits one-month low.  >> Continue reading...
LATEST HEADLINES
>> IBM Stock Downgraded as 200-Day Looms The $138 region in general could be problematic >> Puts Pop as EXAS Heads For Worst Day in 16 Months EXAS was overbought heading into today, too >> LULU Stock Keeps Climbing on Q4 Forecast Lululemon lifted its fourth-quarter sales and profit forecast >> Stock Futures Climb as Trade Deal Signing Approaches Bulls are gearing up for the U.S.-China trade deal signing this week >> How This S&P Volatility Reading Could Play Into a Pullback There are divergences on daily charts to keep an eye on, too Sponsored A rare "private placement" opportunity in cannabis Right now you've got a short window to get in on a tiny new company set upperfectly to dominate the cannabis market. From CBD-infused cosmetic, skin, and pet care products...to medical marijuana...to THC-based consumables...and everything in between...This company's positioned to profit from virtually every kind of pot-based product you can think of. Yet Wall Street's hardly aware of it. Institutional buyers sure are, though, but they can't buy it...yet. It's the most exciting - and overlooked - opportunity in the new cannabis sector today.
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com